pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
TERN-701
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
$TERNTerns Pharmaceuticals, Inc.
0 catalysts
TESTOSTERONE GEL, 1%
TESTOSTERONE GEL, 1% (TESTOSTERONE GEL, 1%)
ENCUBE
0 catalysts
Phase 2
TEV-408
Celiac Disease
$TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
0 catalysts
Preclinical
TEV-56282
Unspecified
Alvotech
← prev
page 164 of 271
next →
131
Pain89
Neurology1
$ALVO
0 catalysts
Preclinical
TEV-56283
Unspecified
$ALVOAlvotech
0 catalysts
TEZSPIRE
TEZSPIRE (TEZEPELUMAB-EKKO)
1 INDICATIONS AND USAGE TEZSPIRE is a thymic stromal lymphopoietin (TSLP) blo…
Thymic stromal lymphopoietin
$AZNASTRAZENECA PLC
0 catalysts
Preclinical
TFD-100
Insulin Resistance
Glycomantra Inc
0 catalysts
Phase 2
TG-01
Pancreatic Cancer
Prostaglandin G/H synthase 2
Circio Holding ASA
0 catalysts
Phase 2
TG-1042
Basal Cell Carcinoma (Basal Cell Epithelioma)
Stamford Pharmaceuticals Inc
0 catalysts
Phase 2
TG-4050
Myvac
Head And Neck Cancer
Transgene SA
0 catalysts
Phase 1
TGI-2
Metastatic Colorectal Cancer
Hefei TG ImmunoPharma Co Ltd
0 catalysts
Phase 1
TGNS-11
Head And Neck Squamous Cell Carcinoma (HNSC)
Toragen Inc
0 catalysts
Preclinical
TGT-001
Charcot-Marie-Tooth Disease Type I A
ToolGen Inc
0 catalysts
Phase 1
TGW-101
Castration-Resistant Prostate Cancer (CRPC)
Tagworks Pharmaceuticals BV
0 catalysts
Phase 2
TH-103
Wet (Neovascular / Exudative) Macular Degeneration
$KLRSKalaris Therapeutics, Inc.
0 catalysts
Preclinical
TH-1904
Ovarian Cancer
Theratechnologies Inc
0 catalysts
Preclinical
TH-1940
Solid Tumor
$CNTNCanton Strategic Holdings, Inc.
0 catalysts
Preclinical
TH-3215
Solid Tumor
$CNTNCanton Strategic Holdings, Inc.
0 catalysts
THALLOUS CHLORIDE TL 201
THALLOUS CHLORIDE TL 201 (THALLOUS CHLORIDE, TL 201)
CURIUM
0 catalysts
THIAMINE HYDROCHLORIDE
THIAMINE HYDROCHLORIDE (THIAMINE HYDROCHLORIDE)
SAGENT PHARMS INC
0 catalysts
Phase 3
THRV-1268
Arrhythmias
$THRYThryv Holdings, Inc.
0 catalysts
Phase 2
TILT-123
Ovarian Cancer
TILT Biotherapeutics Ltd
0 catalysts
TIMOLOL HEMIHYDRATE
TIMOLOL HEMIHYDRATE (TIMOLOL HEMIHYDRATE)
SOMERSET THERAPS LLC
0 catalysts
TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION
TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION (TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION)
GLAND
0 catalysts
TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION, 0.25%
TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION, 0.25% (TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION, 0.25%)
ALEMBIC
0 catalysts
TIROFIBAN
TIROFIBAN (TIROFIBAN)
EUGIA PHARMA
0 catalysts
TISSUEBLUE
TISSUEBLUE (BRILLIANT BLUE G)
DUTCH OPHTHALMIC
0 catalysts
TIVDAK
TIVDAK (TISOTUMAB VEDOTIN-TFTV)
Seagen Inc
0 catalysts
Phase 1
TIX-100
Type 1 Diabetes (Juvenile Diabetes)
Tiximed Inc
0 catalysts
Preclinical
TJ-106
Breast Cancer
Phrontline Biopharma Co Ltd
0 catalysts